البلد: سنغافورة
اللغة: الإنجليزية
المصدر: HSA (Health Sciences Authority)
TELITHROMYCIN
SANOFI-AVENTIS SINGAPORE PTE. LTD.
J01FA15
400 mg
TABLET, FILM COATED
ORAL
Prescription Only
Sanofi-Aventis U.S LLC
2003-02-17
[SANOFI-AVENTIS LOGO] 1. NAME OF THE MEDICINAL PRODUCT Ketek 400 mg film-coated tablets. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet Ketek contains 400 mg of telithromycin. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. Light orange, oblong, biconvex tablet, imprinted with H3647 on one side and 400 on the other. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS When prescribing Ketek, consideration should be given to official guidance on the appropriate use of antibacterial agents (See also sections 4.4 and 5.1). Ketek is indicated for the treatment of the following infections: _In patients of 18 years and older: _ -Community-acquired pneumonia, mild or moderate (see section 4.4). -Acute exacerbation of chronic bronchitis 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The recommended dose is 800 mg once a day i.e. two 400 mg tablets once a day. The tablets should be swallowed whole with a sufficient amount of water. The tablets may be taken with or without food. _In patients of 18 years and older, according to the indication, the treatment regimen will be: _ -Community-acquired pneumonia: 800 mg once a day for 7 to 10 days, -Acute exacerbation of chronic bronchitis: 800 mg once a day for 5 days, In the elderly: No dosage adjustment is required in elderly patients based on age alone. In children: Ketek is not recommended for use in children below 12 years of age due to lack of data on safety and efficacy (see section 5.2). Impaired renal function: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In the presence of severe renal impairment (creatinine clearance <30ml/min) with or without co-existing hepatic اقرأ الوثيقة كاملة